Disorders of Hemostasis
Description
Upon viewing this session, you will be able to:
• recognize the risk of thrombosis associated with central venous catheters in children
• review the role of NETs in thrombosis
• identify long acting agents to treat hemophilia as well as agents to treat patients with inhibitors
• recognize gene therapy options for patients with hemophilia
• discern when repeat testing for VWD can be avoided
• appreciate how platelet releasates may be used to predict future disease outcomes
• recognize the risk of thrombosis associated with central venous catheters in children
• review the role of NETs in thrombosis
• identify long acting agents to treat hemophilia as well as agents to treat patients with inhibitors
• recognize gene therapy options for patients with hemophilia
• discern when repeat testing for VWD can be avoided
• appreciate how platelet releasates may be used to predict future disease outcomes
Presenters
- Michael Callaghan
Pricing
| Member Type | Price |
|---|---|
| List Price | $30.00 |
| Active, International, Emeritus, and Honorary Members | $20.00 |
| Associate, International Associate, Student, and Resident Members | $20.00 |
ASH Meeting on Hematologic Malignancies
Hear the latest developments in clinical care, and get answers to your most challenging patient care questions.
Learn more
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
Copyright © 2021 by American Society of Hematology